ImmuPharma PLC announced the appointment of Tim McCarthy as Non-executive Chairman, with immediate effect. He is currently Chairman and Non-Executive Director of Incanthera, Harvard Healthcare and Expedeon Holdings. Mr. McCarthy is also the former Chief Executive Officer and Finance Director of Alizyme plc and Peptide Therapeutics Group plc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 GBX | -2.35% | -6.09% | +24.78% |
06-05 | EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows | AN |
06-05 | ImmuPharma plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.78% | 10.95M | |
+19.41% | 45.51B | |
+38.65% | 39.36B | |
-8.62% | 38.52B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- IMM Stock
- News ImmuPharma plc
- ImmuPharma PLC Appoints Tim McCarthy as Non-Executive Chairman